Table 2. Sub-patent parasitaemia and gametocyte carriage before and after Treatment.
Group | Day 0 | Day 3 | Day 7* | Day 14 | |
AS+SP | Parasitaemia detected by PCR | 84.6% (44/52) | 25.5% (12/47) | 6.5% (3/46) | 4.4% (2/45) |
Gametocytaemia detected by RT-PCR | 11.5% (6/52) | - | 6.5% (3/46) | 4.4% (2/45) | |
AS+SP+PQ | Parasitaemia detected by PCR | 100% (52/52) | 15.7% (8/51) | 8.3% (4/48) | 6.4% (3/47) |
Gametocytaemia detected by RT-PCR | 11.5% (6/52) | - | 8.3% (4/48) | 6.4% (3/47) |
Risk difference between the two treatment groups on day 7: 1.9% (95%CI −8.5% to +12.3%), on day 14: 2% (95%CI −7.2% to +11.2%).